Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Peptides-and-nucleic-acid-sequences-related-to-the-Epstein-Barr-virus

 Biocompatible polyester and production thereof
The object of the present invention is to improve the hydrolyzability in vivo of a biocompatible ...


 Compositions containing a mixture of phosphorus compounds and alkylglycerols
I claim: 1. A tumor inhibiting, therapeutic composition comprising: a. oleylphosphocholine or a ...


 Process for the preparation of taxol and 10-deacetyltaxol
OF THE INVENTION The present invention is based in part on the discovery that the xyloside moiety ...


 IGF-1 analogs
OF INVENTION Synthetic peptides of less than 25 amino acids are provided which are capable of ...


 Compositions and methods for modulating growth of a tissue in a mammal
OF THE INVENTION The invention is directed to compounds, compositions and methods for affecting ...


 Regioselective substitutions in cyclodextrins
OF THE INVENTION Herein we disclose the use of controlled basic reaction conditions to provide ...


 Substituted cyclodextrins and process for chromatographic separation of chiral organic compounds
We claim: 1. A substituted cyclodextrin of the formula ##STR3## in which R.sup.2, R.sup.3 and R.sup....


 Process for the preparation of a 2-substituted 3,3-difluorofuran
I claim: 1. A process for the preparation of a 2',2'-difluoronucleoside which comprises: reacting a ...


 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester
OF THE INVENTION The stability of the prodrug has always been limited by the occurrence of ...


 Phospholipid and propylene glycol based lubricant
OF THE INVENTION Throughout this specification, unless the context requires otherwise, the word "C...


 Peptides and nucleic acid sequences related to the Epstein Barr virus

Details
Inventors: Middeldorp, Jaap M.; van Grunsven, Wouterus M. J.;
Assignee: Akzo Nobel, N.V. (Arnhem, NL)
Primary Examiner: Brusca; John S.
Assistant Examiner: Kim; Young
Attorney, Agent or Firm: Myers Bigel Sibley & Sajovec

The present invention relates to peptides immunochemically reactive with antibodies to the Epstein-Barr virus (EBV), nucleic acid sequences encoding these peptides, monoclonal antibodies against these peptides, cell lines capable of producing monoclonal antibodies and anti-idiotype antibodies. The invention also relates to recombinant vector molecules comprising a nucleic acid sequence according to the invention and host cells transformed or transfected with these vector molecules. The invention is further concerned with immunological reagents and methods for the detection of EBV or anti-EBV antibodies and a method for the amplification and detection of Epstein Barr viral nucleic acid.

DETAILED DESCRIPTION OF THE INVENTION The term "peptide" as used herein refers to a molecular chain of amino acids with a biological activity, and does not refer to a specific length of the product.
Thus inter alia, proteins, fusion-proteins or -peptides oligopeptides and polypeptides are included.
If required peptides according to the invention can be modified in vivo or in vitro, for example by glycosylation, amidation, carboxylation or phosphorylation.
Functional variants like, for example, acid addition salts, amides, esters, and specifically C-terrminal esters, and N-acyl derivatives of the peptides according to the invention are therefore also considered part of the present invention.
It will be understood that for the particular proteins or polypeptides embraced herein, natural variations can also exist.
These variations may be demonstrated by (an) amino acid difference(s) in the overall sequence or by deletions, substitutions, insertions, inversions or additions of (an) amino acid(s) in said sequence.
Amino acid substitutions from which can be expected that they do not essentially alter biological and immunological activities, have been described.
Amino acid replacements between related amino acids or replacements which have occurred frequently in evolution are, inter alia Ser/Ala, Ser/Gly, Asp/Gly, Asp/Asn, Ile/Val (see Dayhof, M.
D.
, Atlas of protein sequence and structure, Nat.
Biomed.
Res.
Found.
, Washington D.
C.
, 1978, vol.
5, suppl.
3).
Based on this information Lipman and Pearson developed a method for rapid and sensitive protein comparison (Science 227, 1435-1441, 1985) and determining the functional similarity between homologous proteins.
The term "fragment" as used herein means an amino acid sequence comprising a subsequence of a peptide of the invention.
Said fragment is a peptide having one or more immunogenic determinants of the VCA-p18 or VCA-p40 protein.
Fragments can inter alia be produced by enzymatic cleavage of precursor molecules, using restriction endonucleases for the DNA and proteases for the polypeptides



Related patents
  Mammalian expression vectors
The present invention provides a vector system that allows the rapid and effective screening of recombinant constructs by the use of a novel vector. The vector ...
  Process for the preparation of instant cooking alimentary paste
I claim: 1. A method of preparing instant-cooking alimentary paste, comprising the following steps: (a) introducing a mixture of cereal flour and water into an extrusion ...
  Water-soluble mixed ethers of .beta.-cyclodextrin and a process for their preparation
What is claimed is: 1. A water-soluble mixed ether of .beta.-cyclodextrin wherein each ether substituent is a member selected from the group consisting of C.sub.1 and C....
  Separation and purification of cyclodextrins
What is claimed is: 1. A method for sequentially separating different cyclodextrins from a solution containing said different cyclodextrins comprising the steps of: (a) ...
  Anti-inflammatory furanones
What is claimed is: 1. A compound of the formula: ##STR8## in which: the dotted line represents absence of a bond or a single bond; R.sub.1 is hydrogen, C.sub.1 -C.sub.4 ...
  Cyclodextrin polymers and cyclodextrins immobilized on a solid surface
OF THE INVENTION The invention is directed to a polyionic derivative of a cyclodextrin polymer or a polyionic derivative of at least one cyclodextrin immobilized on a ...
  Pharmaceutical formulations for parenteral use
OF THE INVENTION The term "lipophilic" is used herein to describe drugs which are lipid-soluble and hydrophobic, i.e. which are insoluble or sparingly soluble in water. ...
  Automatic dishwashing compositions comprising quaternary substituted bleach activators
OF THE INVENTION Preferred ADD compositions of this invention are substantially free of chlorine bleach. By "substantially free" of chlorine bleach is meant that the ...
  Antitartar composition and its use in food supplements for animals
OF THE INVENTION In accordance with the invention, the expression "to control tartar" means not only to avoid or limit the formation of tartar but also to destroy ...
  Chitin extract for treatment of skin disease
OF A PREFERRED EMBODIMENT I. Preparation of CSE In general, CSE was prepared from commercially available chitin (Fluka, Sigma) as described in U.S. Pat. No. 4,701,444. A...

0.034

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved